APOE and Alzheimer disease: Further, in the future, we warrant and suggest that the gender and genetic variability bases particularly for late-onset AD associated with ApoE4 carrier-based studies as well as in the context of lifestyle should be designed and investigated in the aging preclinical animal models of neurodegenerative diseases.